The FDA claims the wearable tech company's BPI offering is 'adulterated' and 'misbranded,' and is being sold without the proper regulatory approvals.

Plaintiffs allege that CRISP and its subsidiary willfully infringed on patented technology by launching a copycat product ...

In a panel discussion, IT professionals and health system executives discussed the challenges of implementing AI across ...

Researchers from Asan Medical Center, one of South Korea's largest hospitals, have developed a generative AI model that can ...

Mattel announced that it has partnered with type 1 diabetes research and advocacy organization Breakthrough T1D to create and ...

Through the alliance, Hippocratic AI's generative AI healthcare agents will be constructed for "patient-facing non-diagnostic ...

Also, four tuberculosis screening AI solutions from Asia-Pacific are among those recommended by the World Health Organization ...

AI and synthetic-driven research can help clinicians gain a patient's trust, according to Adrienne Boissy, Qualtrics CMO.

The Focalist system aims to combine handheld robotics with real-time imaging to enable clinicians to place needles more ...

The new firm, TandemAI will offer partners an expanded range of methods and workflows for small-molecule and peptide drug ...

Unveiled at Galaxy Unpacked, the new lineup includes sleep apnea detection, vascular stress monitoring and the first ...

Phil, a company focused on pharmaceutical commercialization, has secured $60 million in growth debt financing from K2 ...